Work

Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC

Year: 2020

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2020.11.015

Authors: Jessica A. Hellyer, Sukhmani K. Padda, Maximilian Diehn, Heather A. Wakelee

Institutions: Stanford Medicine, Stanford Cancer Institute, Stanford University, Institute for Stem Cell Biology and Regenerative Medicine

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Novartis, Gilead Sciences, Celgene, Boehringer Ingelheim, Exelixis, ACEA Biosciences, Clovis Oncology, Bayer Fund, EpicentRx, G1 Therapeutics, MedImmune, Genentech, Roche Diagnostics

OpenAlex ID: W3111121302

FWCI: 3.694

Cites: 66

Cited by: 80

Related to: 10